Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance

N.L. de Groot; H.G. van Haalen; B.M. Spiegel; L. Laine; A. Lanas; J.J. Focks; P.D. Siersema; M.G.H. van Oijen

Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance

Translated title of the contribution: Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance

N.L. de Groot, H.G. van Haalen, B.M. Spiegel, L. Laine, A. Lanas, J.J. Focks, P.D. Siersema, M.G.H. van Oijen

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance
Original language	Undefined/Unknown
Pages (from-to)	341-357
Number of pages	17
Journal	Cardiovascular Drugs and Therapy
Volume	27
Publication status	Published - 2013

Cite this

@article{bf6977baecec4e7e82584538b085c30c,

title = "Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance",

author = "{de Groot}, N.L. and {van Haalen}, H.G. and B.M. Spiegel and L. Laine and A. Lanas and J.J. Focks and P.D. Siersema and {van Oijen}, M.G.H.",

year = "2013",

language = "Undefined/Unknown",

volume = "27",

pages = "341--357",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

}

TY - JOUR

T1 - Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance

AU - de Groot, N.L.

AU - van Haalen, H.G.

AU - Spiegel, B.M.

AU - Laine, L.

AU - Lanas, A.

AU - Focks, J.J.

AU - Siersema, P.D.

AU - van Oijen, M.G.H.

PY - 2013

Y1 - 2013

M3 - Article

SN - 0920-3206

VL - 27

SP - 341

EP - 357

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

ER -